Ability to understand and willingness to sign a written informed consent document 
Age ≥ 18 years 
Histologic diagnosis of chondrosarcoma, verifiable after enrollment 
Measurable disease 
Previously treated or incurable disease without options for standard of care therapy 
ECOG performance status of 0-2 
Life expectancy of > 3 months 
For patients of reproductive potential (males and females), use of reliable means for contraception (e.g., contraceptive pill, intrauterine device [IUD], physical barrier) throughout the trial and for 1 year following their final exposure to study treatment 

NCT00543712_inc_T1
Person
Age
NCT00543712_inc_T2
Value
≥ 18 years
NCT00543712_inc_T3
Condition
chondrosarcoma
NCT00543712_inc_T4
Measurement
Histologic
NCT00543712_inc_T8
Measurement
ECOG performance status
NCT00543712_inc_T9
Value
0-2
NCT00543712_inc_T10
Observation
Life expectancy
NCT00543712_inc_T11
Value
> 3 months
NCT00543712_inc_T12
Condition
reproductive potential
NCT00543712_inc_T13
Procedure
contraception
NCT00543712_inc_T14
Drug
contraceptive pill
NCT00543712_inc_T15
Device
intrauterine device [IUD]
NCT00543712_inc_T16
Device
physical barrier
NCT00543712_inc_T17
Scope
contraceptive pill, intrauterine device [IUD], physical barrier
NCT00543712_inc_T18
Temporal
throughout the trial
NCT00543712_inc_T19
Temporal
for 1 year following their final exposure